2018 International Congress

Saturday, October 6, 2018

1:45pm-3:15pm

Directional Lead Impedances and Their Possible Effects on Deep Brain Stimulation

L. Juarez Paz, A. Dalal Kirsch, F. Steigerwald, C. Matthies, S. Meoni, V. Fraix, T. Ten Brinke, R. de Bie, K. Wynants, D. Blum, N. Van Dyck, PR. Schuurman, E. Moro, S. Chabardes, J. Volkmann (Valencia, CA, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Dissecting molecular signatures of X-linked dystonia-parkinsonism (XDP) through integrative genomics studies

A. Domingo, S. Sharma, A. Aneichyk, W. Hendriks, Y. Yadav, D. Shin, D. Gao, C. Vaine, B. Currall, N. Kulkarni, T. Multhaupt-Buell, E. Penney, M. Dy, C. Go, RD. Jamora, R. Rosales, M. Ang, U. Müller, C. Klein, P. Acuña, X. Breakefield, L. Ozelius, DC. Bragg, M. Talkowski (Boston, MA, USA)

Genetics (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease

L. Boon, N. Prent, W. Potters, M. Caan, H. Berendse, R. de Bie, P. vd Munckhof, P. Schuurman, A. van Rootselaar (Amsterdam, Netherlands)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG

1:45pm-3:15pm

Distinct abnormality of movement-related cortical potential between patients with Holmes tremor and cerebellar degeneration

M.K. Lu, J.C. Chen, S.M. Liu, C.H. Tsai (Taichung, Taiwan)

Neurophysiology (Non-PD)  ·  Hall 3FG

1:45pm-3:15pm

Does altering medication to avoid dyskinesia positively alters the breadth of the motor repertoire of patients with Parkinson’s disease? A pilot study

S. Bogard, E. Goubault, K. Lebel, C. Duval (Montreal, QC, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Does motor laterality affect the development of dyskinesia in patients with Parkinson’s disease?

S. Chung, H. Yoo, J. Oh, J. Kim, P. Lee, Y. Sohn (Seoul, Republic of Korea)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Does Niemann Pick Type C heterozygosity predispose to late-onset neurodegeneration?

T. Bremova, C. Sztatecsny, M. Moser, A. Rominger, T. Stephan, J. Havla, K. Hartmann, D. Clevert, M. Strupp, S. Schneider (Munich, Germany)

Rare Genetic and Metabolic Diseases  ·  Hall 3FG

1:45pm-3:15pm

Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG

1:45pm-3:15pm

Dopaminergic impairments following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin through inflammatory cytokines in rats

R. Shukla, R. Gupta, S. Goel, A. Pant, V. Khanna (Bhopal, India)

Drug-Induced Movement Disorders  ·  Hall 3FG

1:45pm-3:15pm

Dopaminergic medication changes affect cognitive, mood, and quality of life outcomes after STN DBS

D. Floden, O. Hogue, M. Saupe, R. Busch, K. Wilson, A. Ahmed (Cleveland, OH, USA)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG